Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.
about
Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasionDo altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular diseaseConstruction of a metastasis-associated gene subtracted cDNA library of human colorectal carcinoma by suppression subtraction hybridization.Identification of molecular characteristics induced by radiotherapy in rectal cancer based on microarray data.Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells.Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancerMicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4.miR-21: a small multi-faceted RNA.Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradationRole of COX-2 inhibitors in cancer therapy.Towards universal screening for colon cancer: a cheap, reliable, noninvasive test using gene expression analysis of rectal swabs.Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma.Downregulation of programmed cell death 4 by inflammatory conditions contributes to the generation of the tumor promoting microenvironmentTumor suppressor gene PDCD4 negatively regulates autophagy by inhibiting the expression of autophagy-related gene ATG5.Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation.Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators.Inhibition by genistein of the lipopolysaccharide-induced down-regulation of programmed cell death 4 in RAW 264.7 mouse macrophages.Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer.Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression.Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.In vivo optical molecular imaging of matrix metalloproteinase activity following celecoxib therapy for colorectal cancer.Cyclooxygenase 2 inhibitors and colon cancer.Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients.Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis and progression of human digestive tract cancers.Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1
P2860
Q24538826-CC2C85C5-7B05-4A9F-815D-11B03D2F635AQ28195582-E4DDC450-2FFD-48F3-943F-0C4B423528ADQ28578102-41F4E3CE-6F4F-4EEA-A3BD-90F1DB33C5BBQ31052792-BA4A4FD6-9B2D-4AC4-B395-A166363314E7Q33597819-94D93C66-E596-4D12-BC67-781FDF1674CFQ33723633-495B51CD-D876-4C8B-AB91-B8F59189E915Q33817129-4A4984AA-03BE-42FD-9643-DED7C5977F76Q34332222-4B1EC484-5394-4870-B075-EC2414877C6BQ34414910-D593059A-8FEE-43CD-8446-ACB19C6CA783Q34931601-F15C5286-0A47-4302-A756-D7E45DC1508FQ35230301-E6464992-4BBB-4463-BE67-CCDDF287F190Q35806751-4DC670A4-16EC-4EA5-9A0E-AC16CD04DB4CQ35825551-B1D5B59E-B7E0-4426-9920-08D97B05418BQ36178297-8AC33F7E-FBC2-4C40-A77A-860A157D036FQ36320431-22D3A6B9-3B36-4A71-89DD-8E03565B29E5Q36892087-46EF16B5-B886-482B-A19C-C2C9F5E81EBCQ37083917-A4688F67-B345-4538-9864-F53A921B5B66Q37323049-2F005A11-1AC2-4F5D-9937-2DA807E9CAB7Q37438657-0915B740-4D4F-4417-BFC7-4D35FC9FC7CEQ38336801-23924643-9251-4E54-AA21-667BC90C20DDQ38954196-BA6DA4A1-6625-4C32-97D3-C5D313C73BC5Q39276818-5F53204F-7D18-492E-B59C-B6272290E90FQ39438243-2585E8AE-C365-4B36-BE1B-67ED137B6878Q39704996-5F994BE1-BB66-4041-8902-BF6EC09ECEA4Q39819644-F0E9AB78-88C2-486F-8DC7-586204A2D9D7Q40020341-CB7511E2-1453-4C02-BC39-7FA8DE78165FQ40314772-091A3594-138C-4183-B50E-736CC9A48BFFQ41836058-BDB38C56-37F2-4A87-80A3-12510A0E8F32Q42048754-C01D4DA0-A629-410E-8CBF-2189E029ECB2Q43853634-04464B60-DC86-4537-934C-19A407D935EAQ44290469-68C5B160-EA3C-49EE-A337-C0AA48C58222Q44432065-717ADF9A-E8A7-4FEC-831E-ADC636B4AF2CQ57144441-C9AC3F14-4C27-4B38-ADA1-B6FC7F6EBE1B
P2860
Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Detection of differentially ex ...... h a selective COX-2 inhibitor.
@en
Detection of differentially ex ...... h a selective COX-2 inhibitor.
@nl
type
label
Detection of differentially ex ...... h a selective COX-2 inhibitor.
@en
Detection of differentially ex ...... h a selective COX-2 inhibitor.
@nl
prefLabel
Detection of differentially ex ...... h a selective COX-2 inhibitor.
@en
Detection of differentially ex ...... h a selective COX-2 inhibitor.
@nl
P2860
P356
P1433
P1476
Detection of differentially ex ...... h a selective COX-2 inhibitor.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204588
P407
P577
2001-07-01T00:00:00Z
P5875
P6179
1027154401